Medical device CE marking

Guidance on clinical trials during COVID-19


On February 4, the EC, EMA and HMA issued a new version (v4) of the Guidance on the management of clinical trials during the COVID-19 (Coronovirus) pandemic.

Key changes from v3 (April 27, 2020): remote source data verification.

The document can be downloaded in our library

Source: European Commission